Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News

08:10 EDT 25th June 2018 | BioPortfolio

Showing News Articles 1–25 of 420,000+

Monday 25th June 2018

LIDDS' NanoZolid® technology recognized through publication of scientific article in Journal of Drug Delivery Science and Technolog

   The international Journal of Drug Delivery Science and Technologywill publish the scientific article in the August edition titled "Cold isostatic pressing of hydrating calcium sulfate as a means to produce parenteral slow-release formulations". The NanoZolid® technology has, over the course of several years, demonstrated its ability to enable a controlled release o...

European Commission Grants Marketing Authorization for Gilead’s Biktarvy® (Bictegravir, Emtricitabine, Tenofovir Alafenamide) for the Treatment of HIV-1 Infection

– In Clinical Trials, Biktarvy Demonstrated High Efficacy and Zero Resistance Through 48 Weeks – Gilead Sciences, Inc. (NASDAQ: GILD) today announced that the European Commission has granted Marketing Authorization for Biktarvy® (bictegravir 50mg/emtricitabine 200 mg/tenofovir alafenamide 25 mg; BIC/FTC/TAF), a once-daily single tablet regimen (ST...

Integrum AB: Bokslutskommuniké 1 maj 2017 - 30 april 2018

PRESSINFORMATION  25 juni 2018 Integrum AB redovisade en nettoomsättning på 15 174 (17 811) KSEK under perioden 2017-05-01 till 2018-04-30 (12 månader), en minskning med 15 % jämfört med motsvarande period föregående år. Samtidigt har satsningen på den amerikanska marknaden gett resultat och omsättningen i USA ökade med 50%. Bolaget har under året kunnat utnyttja det förspr...

Clinipace Expands Leadership Team, Supports New CHALLENGE ACCEPTED Brand

Clinipace, a global full-service contract research organization (CRO), expands its leadership team and launches a new brand identity to support its future growth as a midsized CRO. To better serve its clients, Clinipace is committed to taking a personal approach that focuses on service supported by top CRO talent and technologies.

LabConnect Names New COO and Promotes Two Other Executives

LabConnect, LLC, a leading global provider of central laboratory and support services for biopharmaceutical, medical device and contract research organizations, announces the promotion of three executives to top-level management positions:

ImmunoMolecular Therapeutics’ Scientific Co-founder Presents a Novel Small Molecule Approach to Blocking the Autoimmunity in Type 1 Diabetes

-- Approach presented at the American Diabetes Association 78th Scientific Sessions -- -- Methyldopa found to selectively bind to DQ8, and inhibit the autoimmune cascade. Strong signal for efficacy established in a Phase 1b clinical trial in patients with recent-onset type 1 diabetes --

Pfizer Announces Overall Survival Results from Phase 3 PALOMA-3 Trial of IBRANCE® (Palbociclib) in HR+, HER2- Metastatic Breast Cancer

Results show a positive trend in the secondary endpoint of overall survival, though not reaching statistical significance IBRANCE is approved worldwide in combination with fulvestrant based on compelling results from the primary endpoint of progression-free survival Pfizer today announced overall survival (OS) resul...

FARXIGA in Combination with ONGLYZA Demonstrates Similar Glycemic Control with Additional Benefits Vs. Insulin Glargine in Patients with Type 2 Diabetes

Important short-term and long-term data on a potential new use of Farxiga (dapagliflozin) showed significant reductions in HbA1c in patients with type 1 diabetes AstraZeneca (NYSE: AZN) presented key data on the use of FARXIGA® (dapagliflozin) in diverse patient populations with type 2 and type 1 diabetes (T2D, T1D) at the American Diabetes Associati...

Adolescent Substance Use: Implications for Cancer Prevention

This study statistically ranked states' performance on adolescent substance use related to cancer risk: cigarette smoking, binge alcohol drinking, and marijuana use. Preventing Chronic Disease

Predicting Complications After Abdominal Cancer Surgery

Are there specific clinical factors that might help predict perioperative complications in cancer patients undergoing abdominal surgery? BMC Anesthesiology

Emerging Role of Immunotherapy for Childhood Cancers

Immunotherapeutic strategies are showing promise for pediatric cancers such as leukemia and neuroblastoma. What is the latest research? Chinese Clinical Oncology

Latest Evidence for Particle Therapy in NSCLC

What is the latest evidence on proton therapy for locally advanced lung cancer? Translational Lung Cancer Research

Vizuri Health Sciences LLC Announces the Appointment of Elise Donahue to its Board of Directors.

Vizuri Health Sciences LLC, a pharmaceutical and over-the-counter (OTC) product development company, today announced that the company has further strengthened its consumer healthcare operational and transactional experience by adding Ms. Elise Donahue to its board of directors. William Moore, PhD, Vizuri’s Chief Executive Officer stated, ...

Childhood obesity: government’s plan targets energy drinks and ȷunk food advertising

Banning the sale of energy drinks to children, encouraging primary school pupils to run a mile a day, and restricting junk food advertising are some of the new measures outlined in chapter 2 of the...

Novo’s Ozempic beats Lilly’s Trulicity on weight loss

Novo Nordisk has announced new data showing that its once-weekly glucagon-like peptide 1 (GLP-1) receptor agonist Ozempic provided greater weight reductions than Eli Lilly’s rival drug Trulicity in adults with type II diabetes.

Thomas Jefferson University and Navvis Establish the Nation’s First Nationally-Focused Professorship in Population Health

Private-Public Collaboration Seeks to Improve Health Outcomes Navvis and Thomas Jefferson University’s College of Population Health today announced the country’s first private sector-supported academic chair in population health – The Navvis Professorship of Population Health at Thomas Jefferson University. The Professorship will focus on identif...

Scientists Discover New Gene Expression Mechanism with Possible Role in Human Disease

UNC School of Medicine researchers, led by Brian Strahl, PhD, found surprising role for a protein called Spt6, which is crucial to the maintenance of proper messenger RNA levels in cells, a discovery that opens new research avenues and suggests a target for basic understanding, diagnosis, and treatment of human diseases When cells grow and divide to en...

Synlogic Presents New Preclinical Data from Synthetic Biotic™ Immuno-Oncology Program at FOCIS 2018

- Data highlight broad capabilities of Synlogic’s Synthetic Biotic platform to generate candidates for the potential treatment of cancer – - First program advancing into IND-enabling studies in 2H2018 – Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage drug discovery and development company applying synthetic biology to probiotics to deve...

Biological processing of precious metal ores

The bioeconomy company BRAIN AG and CyPlus GmbH have announced the development of an initial range of market-relevant products for the global mining industry. This work has been carried out as part of a multi-year collaboration between the companies in the area of biological ore processing to extrac...

Tissue Regenix secures HTA license to import CellRight products

Regenerative medical devices group Tissue Regenix has been granted a Human Tissue Authority (HTA) licence to import and distribute its portfolio of human tissue derived products from the US for use in the UK market.

Motus GI Announces Inclusion in the Russell Microcap® Index

Motus GI Holdings, Inc., (NASDAQ:MOTS) (“Motus GI” or the "Company"), a medical technology company dedicated to improving endoscopy outcomes and experiences, announced today that it was added to the Russell Microcap® Index at the conclusion of the Russell indexes annual reconstitution on June 22, 2018. Membership in the Russell Microcap® Index...

Industry Survey Shows 87% of Clinical Operations Leaders Taking Action to Unify Clinical Processes

Better visibility and improved study execution are top drivers; organizations moving to next-generation clinical applications DIA 2018 Annual Meeting — Over the past year, there has been significant industrywide momentum toward streamlining clinical systems and processes, according to one of the largest annual life sciences surveys of clinical operat...

HeartSciences Showcases MyoVista® Wavelet ECG at the 2018 International Congress on Electrocardiology (ICE)

HeartSciences, an innovative medical device company, is proud to announce its participation as an exhibitor at the upcoming 2018 International Congress on Electrocardiology (ICE), which will be held in Makuhari Messe, Chiba City, Japan, June 28-30,

ArQule Added to the Russell 2000® Index

ArQule, Inc. (Nasdaq: ARQL) today announced that it has been added to the Russell 2000® Index, a subset of the Russell 3000® Index, effective as of market closing on June 22, 2018, at the conclusion of the annual Russell US Index reconstitution. "Being included in the Russell Index listings both increases visibility among the investment ...

GTx Added to the Russell 3000® Index

GTx, Inc. (Nasdaq: GTXI) today announced that it has been added to the Russell 3000® Index as part of the Russell U.S. Indexes annual reconstitution. The addition will take effect after the U.S. market opens on June 25. Annual Russell U.S. Indexes reconstitution captures the 4,000 largest U.S. stocks as of May 11, ranking them by total market ca...


Advertisement
Quick Search
Advertisement
Advertisement

 

BioPortfolio's biotechnology, pharmaceutical, healthcare and medical device information service collates press releases, news articles and blogs from over 275 sources.